Leadless Pacing Shows Promise, But Hits Snags

SAN FRANCISCO (MedPage Today) -- Longer-term results from the first-in-man study of the Nanostim leadless pacemaker showed the device continued to work as expected, but a postmarketing study in Europe has been temporarily halted following reports of perforations and deaths. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1ohLTUg